Cargando…
Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost
Autor principal: | Dalakas, Marinos C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518962/ https://www.ncbi.nlm.nih.gov/pubmed/28781610 http://dx.doi.org/10.1177/1756285617717155 |
Ejemplares similares
-
Symptomatic therapy of Duchenne Muscular
Dystrophy (DMD)
por: Rüdel, Reinhardt
Publicado: (2012) -
Recent developments in Duchenne muscular dystrophy: facts and numbers
por: Walter, Maggie C., et al.
Publicado: (2017) -
Estimated costs for Duchenne muscular dystrophy care in Brazil
por: Schneider, Nayê Balzan, et al.
Publicado: (2023) -
Tracking progress: an update on animal models for Duchenne muscular dystrophy
por: Wells, Dominic J.
Publicado: (2018) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)